標(biāo)題: Titlebook: Cardiac Biomarkers; Case Studies and Cli Alan S. Maisel,Allan S. Jaffe Book 2016 Springer International Publishing Switzerland 2016 acute c [打印本頁(yè)] 作者: LANK 時(shí)間: 2025-3-21 19:37
書(shū)目名稱(chēng)Cardiac Biomarkers影響因子(影響力)
作者: canonical 時(shí)間: 2025-3-21 22:41
Nonlinear Phenomena in Stellar Variabilityical imprecision of the assay (the coefficient of variation, CV) should be ≤10 % at the 99th percentile. It is worth remembering that at this point the analytical sensitivity of the available assays, although clinically superior to that of CK and CK-MB measurement was significantly less than those c作者: SUE 時(shí)間: 2025-3-22 01:29
Patterns of Aperiodic Pulsatione second blood sample has been approximately 6 h or later after arrival or symptom onset. This timeframe has been used because early research on cardiac troponins suggested that troponin rises due to myocardial necrosis from acute myocardial infarction (AMI) were not reliably detectable until 6–12 h作者: 險(xiǎn)代理人 時(shí)間: 2025-3-22 07:12 作者: Iniquitous 時(shí)間: 2025-3-22 09:59
S. P?tting,P. Meystre,E. M. Wrightverlooked leading to conclusions that may not be clinically or analytically sound. An understanding of the value and limitations of troponin use is important to all clinicians who manage HF patients. If used optimally, troponin values will likely be helpful in defining when and how to effectively in作者: 沉思的魚(yú) 時(shí)間: 2025-3-22 15:26
Richard E. Slusher,Benjamin J. Eggletoncts with prevalent CV risk factors, diabetics and the elderly. The summarized notion from these investigations is that cTn measurements likely might serve as a ‘gatekeeper’ in the future, in particular to facilitate the identification of subjects with at-risk features in whom additional testing is n作者: 沉思的魚(yú) 時(shí)間: 2025-3-22 19:39
https://doi.org/10.1007/978-3-319-65879-7ic peptide, or BNP, and its N-terminal fragment, NT-proBNP – in screening. Although investigators have debated their cost effectiveness, studies have found that these biomarkers are useful not only in evaluating for current left ventricular dysfunction, but also in predicting future dysfunction, inc作者: RENAL 時(shí)間: 2025-3-22 23:18
Unique Aspects of High Sensitivity Assays: What Are They, Why Do We Need Them, and How Do We Use Theical imprecision of the assay (the coefficient of variation, CV) should be ≤10 % at the 99th percentile. It is worth remembering that at this point the analytical sensitivity of the available assays, although clinically superior to that of CK and CK-MB measurement was significantly less than those c作者: Confidential 時(shí)間: 2025-3-23 03:25
Evaluation of Patients Presenting with Chest Pain in the Emergency Department: Where Do Troponins Fie second blood sample has been approximately 6 h or later after arrival or symptom onset. This timeframe has been used because early research on cardiac troponins suggested that troponin rises due to myocardial necrosis from acute myocardial infarction (AMI) were not reliably detectable until 6–12 h作者: 羊齒 時(shí)間: 2025-3-23 07:21 作者: Disk199 時(shí)間: 2025-3-23 11:46 作者: 范例 時(shí)間: 2025-3-23 17:20
Use of High-Sensitive cTn Assays for the Evaluation of Patients Potentially at Risk for Cardiovasculcts with prevalent CV risk factors, diabetics and the elderly. The summarized notion from these investigations is that cTn measurements likely might serve as a ‘gatekeeper’ in the future, in particular to facilitate the identification of subjects with at-risk features in whom additional testing is n作者: Spirometry 時(shí)間: 2025-3-23 20:39
Natriuretic Peptide Use in Screening in the Communityic peptide, or BNP, and its N-terminal fragment, NT-proBNP – in screening. Although investigators have debated their cost effectiveness, studies have found that these biomarkers are useful not only in evaluating for current left ventricular dysfunction, but also in predicting future dysfunction, inc作者: Truculent 時(shí)間: 2025-3-24 01:04
A. C. Walker,B. S. Wherrett,S. D. Smithausally implicated in atherosclerosis. This book chapter reviews the most important information about TRL, apoB, and LDL-P, and discusses relevant scenarios for the clinician where discordance between lipoprotein cholesterol content and lipoprotein particle concentration measurements should be considered.作者: 殺死 時(shí)間: 2025-3-24 06:23 作者: Lipoma 時(shí)間: 2025-3-24 07:47 作者: 樹(shù)木心 時(shí)間: 2025-3-24 11:40
Newer Lipid Markers: Apolipoprotein B, LDL Particle Concentration, and Triglyceride-Rich Lipoproteinausally implicated in atherosclerosis. This book chapter reviews the most important information about TRL, apoB, and LDL-P, and discusses relevant scenarios for the clinician where discordance between lipoprotein cholesterol content and lipoprotein particle concentration measurements should be considered.作者: Scintigraphy 時(shí)間: 2025-3-24 14:55 作者: embolus 時(shí)間: 2025-3-24 21:29
Heart Failure: Natriuretic Peptide Use in the Hospitaled to ensure patients are appropriate for discharge. If persistent elevation occurs, alternate etiologies for this should be considered and medications should be further up-titrated and optimized prior to discharge.作者: 是限制 時(shí)間: 2025-3-25 00:27
An Overview of Stellar Pulsation Theoryich can confound clinical interpretation and will likely be magnified with high-sensitivity troponin assays. The following case studies and discussion highlight some of these issues and nuances associated with troponin assays.作者: 單獨(dú) 時(shí)間: 2025-3-25 06:43
Nonlinear Phenomena in the Ionosphere2000 (Alpert et al., J Am Coll Cardiol 36:959–969, 2000). As noted above, in this second communication the task force defined five subtypes of MI which were retained with modest changes in the 2012 revision (Thygesen et al., Eur Heart J 33:2551–2567, 2012).作者: 狂熱文化 時(shí)間: 2025-3-25 10:41 作者: Endoscope 時(shí)間: 2025-3-25 12:34
Pre-analytical Factors and Analytical Issues Affecting Interpretation of Cardiovascular Biomarkersich can confound clinical interpretation and will likely be magnified with high-sensitivity troponin assays. The following case studies and discussion highlight some of these issues and nuances associated with troponin assays.作者: ureter 時(shí)間: 2025-3-25 18:57 作者: 可行 時(shí)間: 2025-3-25 22:00 作者: 統(tǒng)治人類(lèi) 時(shí)間: 2025-3-26 00:49 作者: IDEAS 時(shí)間: 2025-3-26 08:10
Book 2016itten by the worlds most respected leaders in biomarkers, with a majority emphasis on what clinicians need to know..The Editors and their contributors have provided algorithms, annotated case discussions and caveats. They cover biomarkers to predict risk of heart disease, biomarkers of cardiorenal d作者: RADE 時(shí)間: 2025-3-26 09:48 作者: 注意力集中 時(shí)間: 2025-3-26 13:53
Atomic Solitons in Optical Latticesnse research and ultimately after the completion of appropriately powered and designed intervention trials based on patient selection by high sensitive cTn level, the role for cTn testing may extend well beyond the patient with AMI.作者: alleviate 時(shí)間: 2025-3-26 20:19
Troponin Basics for Cliniciansr clinicians, in particular emergency physicians and cardiologists, to understand the nuances of cTn testing, as proper understanding of the analytical characteristics of assays will lead to sound clinical implementation and improved research observations.作者: 嘲笑 時(shí)間: 2025-3-27 00:50 作者: 潰爛 時(shí)間: 2025-3-27 03:53
ts clinical information in a practical manner and includes aThis book covers ACS and Heart Failure, the chapters represent the most current, up to date and knowledgeable content on the topic available.?It is written by the worlds most respected leaders in biomarkers, with a majority emphasis on what作者: 橢圓 時(shí)間: 2025-3-27 06:30
Theory of Parametric Photonic Crystals particularly challenging as ischemic and non-ischemic mechanisms frequently co-exist. Understanding the etiology of troponin elevation in critically ill patients is important to better target appropriate therapies for MI in this population.作者: CRANK 時(shí)間: 2025-3-27 11:55 作者: Pituitary-Gland 時(shí)間: 2025-3-27 14:57 作者: 游行 時(shí)間: 2025-3-27 21:51 作者: CHOIR 時(shí)間: 2025-3-28 01:54
Other Biomarkers in Acute Coronary Syndromeional markers that are frequently used in combination with troponin. More recently, novel markers such as pro-ADP, copeptin, and pro-ANP have shown promise in chest pain and may add to the clinical picture. This chapter will discuss the strengths, weaknesses, and supporting data for each of these traditional and novel chest pain biomarkers.作者: 充滿(mǎn)裝飾 時(shí)間: 2025-3-28 05:22 作者: Alveolar-Bone 時(shí)間: 2025-3-28 08:15 作者: 斗爭(zhēng) 時(shí)間: 2025-3-28 11:24 作者: fatty-streak 時(shí)間: 2025-3-28 17:44 作者: 妨礙議事 時(shí)間: 2025-3-28 19:54 作者: Factual 時(shí)間: 2025-3-28 22:58
Nonlinear Phenomena in Stellar Variabilityhift in biochemical testing for the diagnosis of patients presenting with chest pain. For the first time, the laboratory was able to offer a specific diagnostic test for acute myocardial infarction (AMI). Compared to the tests then in use, measurement of creatine kinase (CK) and its MB isoenzyme (CK作者: 外向者 時(shí)間: 2025-3-29 06:34
Patterns of Aperiodic Pulsatione most common patient groups presenting to Emergency Departments in the developed world. These patients account for approximately 10 % of Emergency Department presentations and up to 25 % of hospital admissions (Goodacre et al., Heart 91:229–230, 2005). Up to 90 % of these patients do not have a fin作者: inspired 時(shí)間: 2025-3-29 11:17
https://doi.org/10.1007/978-3-642-87649-3with necrosis and thereby replaced creatine kinase isoenzyme MB (CKMB) as the biomarker of choice in the Universal Definition of Myocardial Infarction. Over the last two decades the analytical sensitivities of troponin assays have been constantly improved which has resulted in an improved early diag作者: 無(wú)力更進(jìn) 時(shí)間: 2025-3-29 12:07 作者: ureter 時(shí)間: 2025-3-29 18:21
S. P?tting,P. Meystre,E. M. Wrightnterpretation, limitation of values, and their best use in heart failure (HF) patients. The objective of this chapter is to provide a balanced assessment of how cardiac troponins are advocated for clinical use in HF patients and areas where there are gaps in knowledge that are important for clinicia作者: Adrenaline 時(shí)間: 2025-3-29 19:59
Theory of Parametric Photonic Crystals is associated with adverse long-term outcomes, irrespective the exact underlying reason. Differentiation between ischemic and non-ischemic reasons is particularly challenging as ischemic and non-ischemic mechanisms frequently co-exist. Understanding the etiology of troponin elevation in critically 作者: Preserve 時(shí)間: 2025-3-30 00:56 作者: 接觸 時(shí)間: 2025-3-30 04:41 作者: 節(jié)約 時(shí)間: 2025-3-30 11:41 作者: gout109 時(shí)間: 2025-3-30 13:11 作者: 送秋波 時(shí)間: 2025-3-30 19:42
O. A. Egorov,D. V. Skryabin,F. Lederersis in humans, NPs are potent vasodilatory hormones that mediate diuresis, natriuresis and cardiac remodeling (Levin et al., N Engl J Med 339(5):321–328, 1998). Neurohormonal signaling plays an essential role in cardiovascular disease. Whereas antagonism of the renin-angiotensin-aldosterone pathway,作者: 發(fā)微光 時(shí)間: 2025-3-30 23:13
Photonic Transition in Nanophotonics,rt failure. As with the analysis of any biomarker, the analytical attributes of the assay for B-type natriuretic peptide and NT-proBNP can influence the interpretation of results. Point-of-care testing is an attractive alternative to sending samples to a central laboratory. The advantage of getting 作者: Chagrin 時(shí)間: 2025-3-31 03:25
https://doi.org/10.1007/978-3-319-65879-7mptomatic individuals at risk to those suffering symptoms even at rest. In between are patients with silent left ventricular dysfunction, which is often only diagnosed after an abnormal electrocardiogram or chest imaging is obtained during workup for other medical conditions. One in 10 of such indiv作者: 的染料 時(shí)間: 2025-3-31 08:55
The Dynamics and Physics of ENSO,erformed diagnostics, that of taking a history and physical, or limited by their poor accuracy, and the most accurate determinates are not available in a fashion early enough for emergency medicine usage. Because they are available shortly after emergency department presentation, natriuretic peptide作者: 母豬 時(shí)間: 2025-3-31 12:07 作者: IVORY 時(shí)間: 2025-3-31 15:53 作者: sparse 時(shí)間: 2025-3-31 19:46 作者: atopic-rhinitis 時(shí)間: 2025-4-1 00:39 作者: NATAL 時(shí)間: 2025-4-1 05:10
Troponin Basics for Clinicianspe 1–5 acute myocardial infarction), due to cTn’s high myocardial tissue specificity and high clinical sensitivity [1]. cTn are regulatory proteins with both cytosolic (predominant) and structural pools (minor) [2]. Clinical implementation of cTnT and cTnI assays in the late 1980s revolutionized the
